IRTC

Irhythm Holdings Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↑ 8/10
  • Momentum↓ 3/10
Irhythm Holdings sales and earnings growth
IRTC Growth
Good
  • Revenue Y/Y↑ 26.24%
  • EPS Y/Y↑ 61.71%
  • FCF Y/Y↑ 212.99%
Irhythm Holdings gross and profit margin trends
IRTC Profitability
Neutral
  • Gross margin ↑ 70.60%
  • EPS margin↓ -6.00%
  • ROIC↓ -2.40%
Irhythm Holdings net debt vs free cash flow
IRTC Risk
Poor
  • Debt / Equity↑ 4.8
  • Debt / FCF↑ 14.1
  • Interest coverage↓ -2.3

Irhythm Holdings stock is less volatile than the overall market, so it's low risk. We give it a Poor risk rating.

More Medical Devices stocks ↗